Kindai University Scientists Cut Amyloid Buildup in 2 Alzheimer’s Models With Arginine
Updated
Updated · SciTechDaily · May 13
Kindai University Scientists Cut Amyloid Buildup in 2 Alzheimer’s Models With Arginine
1 articles · Updated · SciTechDaily · May 13
Arginine reduced toxic amyloid-β buildup in fruit fly and mouse Alzheimer’s models, while treated mice also showed less brain inflammation and better maze performance.
Lab tests found the amino acid directly curbed Aβ42 fibril formation; higher concentrations produced stronger anti-aggregation effects, and electron microscopy showed shorter, less developed fibers.
In AppNL-G-F mice given arginine in drinking water early, plaque burden fell in the hippocampus and cortex, with insoluble Aβ42 dropping while soluble amyloid levels stayed largely unchanged.
The findings point to a prevention-focused strategy for a disease affecting more than 50 million people, using a low-cost compound with an established safety record rather than expensive antibody drugs that can cause ARIA.
Researchers cautioned the work remains preclinical, the dosing does not match over-the-counter supplements, and larger animal and human studies are still needed.
If an amino acid prevents dementia, should we rethink the entire expensive drug-and-screening approach to Alzheimer's?
This supplement shows promise against Alzheimer's. Is it a safe preventive strategy or a risky self-experiment?
Arginine Supplementation Shows Dramatic Amyloid Reduction in Alzheimer’s Models: New Hope from Kindai University
Overview
Kindai University and its partners have made a significant breakthrough in Alzheimer's research by discovering that oral arginine can greatly reduce the buildup of amyloid-β plaques in animal models. These plaques are a hallmark of Alzheimer's and are known to contribute to both neurodegeneration and cognitive decline. The study provides strong proof of concept that simple nutritional or pharmacological supplementation with arginine could potentially lower amyloid pathology and improve neurological health. This finding opens up a promising new approach for Alzheimer's treatment, offering hope for more accessible and less invasive therapies in the future.